Stay updated on IBI310 and Siltilimab in NPC Clinical Trial

Sign up to get notified when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IBI310 and Siltilimab in NPC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record.
    Difference
    0.8%
    Check dated 2026-10-21T21:53:16.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The displayed site revision changes from v3.7.1 to v3.7.2; the study record history remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-14T21:56:27.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site footer now displays software revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-07T22:04:45.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the record history, representing an updated version of the study record. The previous revision v3.6.6 was removed from the history, updating the version list.
    Difference
    0.1%
    Check dated 2026-09-16T21:38:03.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 is added to the record history. The previous revision v3.6.5 is removed, updating the study record's version history.
    Difference
    0.1%
    Check dated 2026-09-02T19:07:34.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    A new revision entry was added updating the page version from v3.6.4 to v3.6.5. This reflects a new release of the study record page on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-08-12T09:26:42.000Z thumbnail image

Stay in the know with updates to IBI310 and Siltilimab in NPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.